DATE: November 13, 2019
TIME: 12:00pm PST
NK cells play a major role in immune surveillance and in the early immune response to cancer and infections. Beneficial anti-tumor responses have been observed, illustrating the safety profile and clinical potential of this treatment. With an increasing availability of anti-cancer drugs, the role of NK cell-based approaches in novel combination therapies has rapidly escalated.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.